Literature DB >> 6511990

Time-dependent absorption of theophylline in man.

H Watanabe, S Nakano, K Nagai, N Ogawa.   

Abstract

Sixteen healthy volunteers were given either oral or intravenous doses of aminophylline (125 mg) at 9:00 A.M. and 9:00 P.M. under controlled food conditions. Measured at regular time intervals by homogeneous enzyme immunoassay, the plasma theophylline concentrations 1.5 and 2 hours after oral aminophylline were significantly higher in the morning than in the evening (P less than 0.05). Also, the mean peak plasma concentration was significantly higher (P less than 0.05) and the time to peak concentration was faster (P = 0.02) after the morning dose. Neither the morning mean elimination half-life nor the morning mean area under the plasma concentration-time curve differed significantly from those after the evening dose. After intravenous aminophylline, no significant differences were found in the plasma theophylline concentrations and in the elimination half-life between morning and evening. Therefore, the small but statistically significant time-dependent differences in theophylline kinetics must be due to changes in absorption from the gastrointestinal tract and not to changes in distribution or elimination of the drug.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6511990     DOI: 10.1002/j.1552-4604.1984.tb02760.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  8 in total

1.  Is diurnal variation in absorption of slow-release aminophylline an age-related phenomenon?

Authors:  A Rodgers; D N Bateman; K W Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects.

Authors:  A Fujimura; Y Kumagai; K Sugimoto; H Nakashima; H Kajiyama; A Ebihara; K Ohashi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.

Authors:  H Chrystyn; J W Ellis; B A Mulley; M D Peake
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

4.  The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.

Authors:  H Lamont; R Pauwels; M Van der Straeten
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

5.  Effects of time of dosing and age on intravenous aminophylline pharmacokinetics.

Authors:  A Rodgers; K W Woodhouse; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

6.  The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects.

Authors:  T Shiga; A Fujimura; T Tateishi; K Ohashi; A Ebihara
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 7.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

Review 8.  Chronopharmacology: new insights and therapeutic implications.

Authors:  Robert Dallmann; Steven A Brown; Frédéric Gachon
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-16       Impact factor: 13.820

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.